BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18772454)

  • 21. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes.
    Westerberg LS; Meelu P; Baptista M; Eston MA; Adamovich DA; Cotta-de-Almeida V; Seed B; Rosen MK; Vandenberghe P; Thrasher AJ; Klein C; Alt FW; Snapper SB
    J Exp Med; 2010 Jun; 207(6):1145-52. PubMed ID: 20513746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities of follicular helper T-cell number and function in Wiskott-Aldrich syndrome.
    Zhang X; Dai R; Li W; Zhao H; Zhang Y; Zhou L; Du H; Luo G; Wu J; Niu L; An Y; Zhang Z; Ding Y; Song W; Liu C; Zhao X
    Blood; 2016 Jun; 127(25):3180-91. PubMed ID: 27170596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cdc42, Rac1, and the Wiskott-Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes.
    Westerberg L; Greicius G; Snapper SB; Aspenström P; Severinson E
    Blood; 2001 Aug; 98(4):1086-94. PubMed ID: 11493455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation.
    Watanabe Y; Sasahara Y; Ramesh N; Massaad MJ; Yeng Looi C; Kumaki S; Kure S; Geha RS; Tsuchiya S
    J Allergy Clin Immunol; 2013 Sep; 132(3):648-655.e1. PubMed ID: 23684068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marginal Zone B Cells Assist With Neutrophil Accumulation to Fight Against Systemic
    Lo LW; Chang CW; Chiang MF; Lin IY; Lin KI
    Front Immunol; 2021; 12():636818. PubMed ID: 34040603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses.
    Cuenca M; Romero X; Sintes J; Terhorst C; Engel P
    J Immunol; 2016 Jan; 196(2):726-37. PubMed ID: 26667173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
    Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
    Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ageing adversely affects the migration and function of marginal zone B cells.
    Turner VM; Mabbott NA
    Immunology; 2017 Jul; 151(3):349-362. PubMed ID: 28369800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
    Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
    J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marginal zone B cells transport IgG3-immune complexes to splenic follicles.
    Zhang L; Ding Z; Xu H; Heyman B
    J Immunol; 2014 Aug; 193(4):1681-9. PubMed ID: 25015822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
    Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
    Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cells.
    Bouma G; Carter NA; Recher M; Malinova D; Adriani M; Notarangelo LD; Burns SO; Mauri C; Thrasher AJ
    Eur J Immunol; 2014 Sep; 44(9):2692-702. PubMed ID: 24945741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells.
    Strom TS; Turner SJ; Andreansky S; Liu H; Doherty PC; Srivastava DK; Cunningham JM; Nienhuis AW
    Blood; 2003 Nov; 102(9):3108-16. PubMed ID: 12855574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WASp Is Essential for Effector-to-Memory conversion and for Maintenance of CD8
    Liu Q; Zhang L; Shu Z; Yu T; Zhou L; Song W; Zhao X
    Front Immunol; 2019; 10():2262. PubMed ID: 31608063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of marginal zone B cells and accelerated loss of follicular dendritic cells in NF-kappaB p50-deficient mice.
    Ferguson AR; Corley RB
    BMC Immunol; 2005 Apr; 6():8. PubMed ID: 15836790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response.
    Westerberg L; Larsson M; Hardy SJ; Fernández C; Thrasher AJ; Severinson E
    Blood; 2005 Feb; 105(3):1144-52. PubMed ID: 15383456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.
    Toscano MG; Frecha C; Benabdellah K; Cobo M; Blundell M; Thrasher AJ; García-Olivares E; Molina IJ; Martin F
    Hum Gene Ther; 2008 Feb; 19(2):179-97. PubMed ID: 18240968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artemisinin attenuates IgM xenoantibody production via inhibition of T cell-independent marginal zone B cell proliferation.
    Liu L; Zhao J; Li A; Yang X; Sprangers B; Li S
    J Leukoc Biol; 2021 Mar; 109(3):583-591. PubMed ID: 32542769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses.
    Rubtsov AV; Swanson CL; Troy S; Strauch P; Pelanda R; Torres RM
    J Immunol; 2008 Mar; 180(6):3882-8. PubMed ID: 18322196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of the Wiskott-Aldrich syndrome protein N-terminal domain in transgenic mice inhibits T cell proliferative responses via TCR signaling without affecting cytoskeletal rearrangements.
    Sato M; Tsuji NM; Gotoh H; Yamashita K; Hashimoto K; Tadotsu N; Yamanaka H; Sekikawa K; Hashimoto Y
    J Immunol; 2001 Oct; 167(8):4701-9. PubMed ID: 11591801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.